| Mrs Jacqueline Marie Steffenhagen, OTR/L | |
|
3305 Central Park Village Dr Ste 130, Eagan, MN 55121-7707 | |
| (651) 406-8868 | |
| Not Available |
| Full Name | Mrs Jacqueline Marie Steffenhagen |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 3305 Central Park Village Dr Ste 130, Eagan, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306928940 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 102413 (Minnesota) | Primary |
| Provider Name | Fairview Health Services |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Injecting botulinum toxin A, or Botox, into the prostate gland of men with enlarged prostate, eased symptoms and improved quality of life up to a year after the procedure, according to a study by researchers at the Chang Gung University Medical College, Taiwan, and the University of Pittsburgh School of Medicine.
New research, partially funded by the U.S. Department of Agriculture and the USA Rice Federation, shows that consumers can improve their diets simply by enjoying white or brown rice as part of their daily meals.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
Revive, a national public relations firm specializing in Health Care and Healthy Living, today released the results of its fourth annual National Payor Survey of hospital executives. The only one of its kind in the country, the survey targeted hospital leaders in the industry who negotiate managed care contracts with national health insurance companies - CEOs, CFOs, and directors of managed care. Participants represent 24% of hospitals in the U.S., up from 18% last year.
Wyeth Pharmaceuticals has announced that the U.S. Food and Drug Administration has granted a new "fast track" designation for temsirolimus (CCI-779), an investigational mTOR kinase inhibitor, in the first-line treatment of poor-prognosis patients with advanced renal cell carcinoma (RCC).
› Verified 2 days ago
| Provider Name | Fairview Express Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Injecting botulinum toxin A, or Botox, into the prostate gland of men with enlarged prostate, eased symptoms and improved quality of life up to a year after the procedure, according to a study by researchers at the Chang Gung University Medical College, Taiwan, and the University of Pittsburgh School of Medicine.
New research, partially funded by the U.S. Department of Agriculture and the USA Rice Federation, shows that consumers can improve their diets simply by enjoying white or brown rice as part of their daily meals.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
Revive, a national public relations firm specializing in Health Care and Healthy Living, today released the results of its fourth annual National Payor Survey of hospital executives. The only one of its kind in the country, the survey targeted hospital leaders in the industry who negotiate managed care contracts with national health insurance companies - CEOs, CFOs, and directors of managed care. Participants represent 24% of hospitals in the U.S., up from 18% last year.
Wyeth Pharmaceuticals has announced that the U.S. Food and Drug Administration has granted a new "fast track" designation for temsirolimus (CCI-779), an investigational mTOR kinase inhibitor, in the first-line treatment of poor-prognosis patients with advanced renal cell carcinoma (RCC).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jacqueline Marie Steffenhagen, OTR/L 2865 Upper 62nd St E, Inver Grove Heights, MN 55076-1538 Ph: (651) 451-4406 | Mrs Jacqueline Marie Steffenhagen, OTR/L 3305 Central Park Village Dr Ste 130, Eagan, MN 55121-7707 Ph: (651) 406-8868 |
News Archive
Injecting botulinum toxin A, or Botox, into the prostate gland of men with enlarged prostate, eased symptoms and improved quality of life up to a year after the procedure, according to a study by researchers at the Chang Gung University Medical College, Taiwan, and the University of Pittsburgh School of Medicine.
New research, partially funded by the U.S. Department of Agriculture and the USA Rice Federation, shows that consumers can improve their diets simply by enjoying white or brown rice as part of their daily meals.
Pfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.
Revive, a national public relations firm specializing in Health Care and Healthy Living, today released the results of its fourth annual National Payor Survey of hospital executives. The only one of its kind in the country, the survey targeted hospital leaders in the industry who negotiate managed care contracts with national health insurance companies - CEOs, CFOs, and directors of managed care. Participants represent 24% of hospitals in the U.S., up from 18% last year.
Wyeth Pharmaceuticals has announced that the U.S. Food and Drug Administration has granted a new "fast track" designation for temsirolimus (CCI-779), an investigational mTOR kinase inhibitor, in the first-line treatment of poor-prognosis patients with advanced renal cell carcinoma (RCC).
› Verified 2 days ago
Colette R Brogan, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3305 Central Park Village Dr, Eagan, MN 55121 Phone: 651-406-8860 | |
Mrs. Catherine Claire Schwartz, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd, Eagan, MN 55121 Phone: 651-994-9644 | |
Stacey Wiles, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd Ste 100, Eagan, MN 55121 Phone: 651-994-9644 | |
Anne Endrizzi, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd, Suite 100, Eagan, MN 55121 Phone: 651-994-9644 Fax: 651-994-8962 | |
Allison V Mikota, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1185 Town Centre Dr Ste 100, Eagan, MN 55123 Phone: 651-968-5230 Fax: 651-994-5200 | |
Mandy Sans Crainte, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd Ste 100, Eagan, MN 55121 Phone: 651-994-9644 | |
Maureen C Scanlan, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3294 Rolling Hills Dr, Eagan, MN 55121 Phone: 651-686-7145 |